The HIV Research for Prevention (HIVR4P) conference was held in Madrid, Spain, from 21 to 25 October 2018. Voluntary medical male circumcision (VMMC) for HIV prevention was examined in five posters, including a 24 October late-breaker on whether VMMC services increased HIV testing uptake among young men in Kisumu, Kenya.

VMMC was also a focus of a symposium on the design of HIV prevention trials in an era of proven HIV prevention tools.

Links to the VMMC presentations in the conference programme are provided below. Some of the posters are available here.

Tuesday, 23 October

Poster Sessions

Venue: Poster Hall    Time: 17:30 – 19:30


Voluntary Medical Male Circumcision Uptake Among M-F+ HIV Serodiscordant Couples

Presenter: Hanzunga Halumamba, Zambia Emory HIV Research Project, Zambia

In: Contraception, Pregnancy and HIV Prevention



Acceptability of Infant Circumcision Among Traditionally Circumcising Communities in Kenya: Views of Traditional Circumcisers and Councils of Elders

Presenter: Kawango Agot, Impact Research & Development Organization, Kenya

In: Implementation Science, Including Structural Interventions, PrEP & VMMC



Circumcision Increases the Barrier Function of the Glans Epithelium

Presenter: Gianguido C. Cianci, Feinberg School of Medicine, Northwestern University, United States

In: Transmission of HIV


Wednesday, 24 October

Poster Session

Venue: Poster Hall    Time: 17:30 – 19:30


Do VMMC Strategies Increase HIV Testing and Proportion of Positive Among Young Men Compared to Non-VMMC Strategies in Kisumu County?

Presenter: Harriet Fridah Adhiambo, Kenya Medical Research Institute, Kenya

In: Implementation Science, Including Structural Interventions, PrEP & VMMC


Poster Discussion Session

Venue: Bristol    Time: 16:45 – 17:30


Profile of the Uncircumcised Zambian Male After Seven Years of Circumcision Programs for HIV Prevention

Presenter: Omega Chituwo, Centers for Disease Control and Prevention, Zambia

In: MEN-ding the Gaps



Venue: Oxford    Time: 15:00 – 16:30

Beyond Placebo: Designing and Implementing Next Generation HIV Prevention Trials

Chairs: Peter Godfrey-Faussett, UNAIDS, Switzerland; Catherine Hankins, Amsterdam Institute for Global Health and Development, Netherlands